当前位置:首页 - 行情中心 - 沃华医药(002107) - 财务分析 - 现金流量表

沃华医药

(002107)

  

流通市值:42.00亿  总市值:42.42亿
流通股本:5.71亿   总股本:5.77亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金658,255,661.37448,628,127.59254,343,800.74901,655,983.68
  收到其他与经营活动有关的现金8,454,658.095,602,513.812,637,506.0218,412,574.39
  经营活动现金流入小计666,710,319.46454,230,641.4256,981,306.76920,068,558.07
  购买商品、接受劳务支付的现金105,887,109.9777,155,760.1935,923,956.37144,453,343.17
  支付给职工以及为职工支付的现金119,896,853.3384,199,299.9245,414,042.37164,025,095.58
  支付的各项税费85,654,905.655,927,843.6728,917,159.49111,891,470.14
  支付其他与经营活动有关的现金233,931,686.88155,580,235.1479,082,777.32371,173,033.18
  经营活动现金流出小计545,370,555.78372,863,138.92189,337,935.55791,542,942.07
  经营活动产生的现金流量净额121,339,763.6881,367,502.4867,643,371.21128,525,616
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额---14,653,572
  处置子公司及其他营业单位收到的现金净额---820,000
  投资活动现金流入的平衡项目---0
  投资活动现金流入小计---15,473,572
  购建固定资产、无形资产和其他长期资产支付的现金1,421,860.971,095,065.21717,575.21864,503.16
  投资活动现金流出小计1,421,860.971,095,065.21717,575.21864,503.16
  投资活动产生的现金流量净额-1,421,860.97-1,095,065.21-717,575.2114,609,068.84
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金150,167,000.3387,800,601.687,800,601.690,825,152
  其中:子公司支付给少数股东的股利、利润3,528,0003,528,0003,528,00021,560,000
  支付其他与筹资活动有关的现金666,281.43383,684.88101,088.331,147,932.68
  筹资活动现金流出小计150,833,281.7688,184,286.4887,901,689.9391,973,084.68
  筹资活动产生的现金流量净额-150,833,281.76-88,184,286.48-87,901,689.93-91,973,084.68
五、现金及现金等价物净增加额-30,915,379.05-7,911,849.21-20,975,893.9351,161,600.16
  加:期初现金及现金等价物余额394,037,806.06394,037,806.06394,037,806.06342,876,205.9
  期末现金及现金等价物余额363,122,427.01386,125,956.85373,061,912.13394,037,806.06
补充资料:
  净利润-71,033,118.92-88,791,071.62
  资产减值准备-542,347.16-1,950,661.77
  固定资产和投资性房地产折旧-14,462,850.5-29,205,157.78
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-14,462,850.5-29,205,157.78
  无形资产摊销-653,887.8-1,368,526.28
  处置固定资产、无形资产和其他长期资产的损失--1,502.59--
  固定资产报废损失-2,070.55-170,469.99
  财务费用-18,767.58-62,306.1
  投资损失----1,763,146.58
  递延所得税--160,347.5-205,752.52
  其中:递延所得税资产减少-32,552.5-679,115.63
    递延所得税负债增加--192,900--473,363.11
  存货的减少--16,451,333.54-11,720,945.6
  经营性应收项目的减少-15,323,607.82-3,301,923.17
  经营性应付项目的增加--3,791,799.9--4,306,270.2
  现金的期末余额-386,125,956.85-394,037,806.06
  减:现金的期初余额-394,037,806.06-342,876,205.9
  现金及现金等价物的净增加额--7,911,849.21-51,161,600.16
公告日期2026-10-102026-07-162026-04-082026-01-20
审计意见(境内)标准无保留意见
TOP↑